Beau's lines after chemotherapy for ALL.
Miyoshi
Isao
I
Department of Medicine, Kochi University School of Medicine.
Kubota
Tetsuya
T
Taguchi
Hirokuni
H
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009262:Nails / Q000187:drug effects* / Q000254:growth & development / Q000473:pathology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D001215:Asparaginase